DAFTAR PUSTAKA
1. Humaera R., Mustofa [Link] dan Penatalaksaanaan Karsinoma Mammpa Stadium 2.
J Medula Unila. 2017;7(2): 103-7.
2. Balekouzou A., Yin P., Pamatika C.M., Bishwajit G., Nambei S.W. Djeintote M., et al.
Epidemiology of breast cancer: retrospective study in the Central African Republic. BMC
Public Health.2016;16(1230):1-10
3. Hartaningsih, Sudarsa I.W. Kanker Payudara pada Wanita Usia Muda Di Bagian Bedah
Onkologi Rumah Sakit Umum Pusat Sanglah Denpasar Tahun 2002 – 2012 [skripsi]. Bali:
Univertas Udayana; 2013.
4. Yanagawa, M. Ikemot K., Kawauchi S., Furuya T., Yamamoto S., Oka M. Luminal A and
luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with
different genotype. BMC Research Notes. 2012;5(376): 1-8.
5. Scully, O.J., Bay B.H., Yip G., Yu Y. Breast Cancer Metastasis. Canc Genom & Proteom.
2012;9:311-20.
8. Komite Penanggulangan Kanker Nasional. Panduan Penatalaksanaan Kanker Payudara.
Jakarta: Kementerian Kesehatan Republik Indonesia; 2015.
9. Mukti A.F., Bekti R.S., Roebijoso J. Korelasi Pemeriksaan Human Epidermal Growth
Factor Receptor-2 (Her-2) dengan Stadium Klinis TNM pada Pasien Kanker Payudara di
Instalasi Patologi Anatomi RS dr. Saiful Anwar Periode Januari 2010-Desember 2012.
Majalah Kesehatan FKUB. 2016;3(3):112-20.
11. Baruch A.B. Site-specific metastasis formation. Cell Adhes & Migr J. 2009; 3(4):328-33.
12. Sun, Y.S, Zhao Z., Yang Z., Xu1 F., Lu1 H.J., Zhu1 Z.Y. Risk Factors and Preventions of
Breast Cancer. Int J Biol Sci. 2017;13(11):1387-97.
17. Mohan H. The Breast in Textbook of Pathology 6th ed. India: Jaypee Brothers Medical
Publisher; 2010. p. 754-9.
18. Jin X., Mu P. Targeting Breast Cancer Metastasis. Breast Cancer: Basic and Clinical
Research. 2015;9:23–34.
19. Widodo I., Dwianingsih, E.K, Triningsih E., Utoro T., Soeripto. Clinicopathological
Features of Indonesian Breast Cancers with Different Molecular Subtypes. Asian Pac J
Cancer Prev. 2014;15(15): 6109-13.
20. Maki, D., Grossman, R. Pattern of Disease Spread in Metastatic Breast Carcinoma:
Influence of Estrogen and Progesterone Receptor Status. Am J Neuroradiol. 2000;21:1064-6.
21. Wiguna, N., Manuaba I. Karakteristik Pemeriksaan Imunohistokimia pada Pasien Kanker
Payudara di RSUP Sanglah Periode 2003-2012 [skripsi]. Bali: Univertas Udayana; 2013.
22. Sander, M. Profil Penderita Kanker Payudara Stadium Lanjut Baik Lokal Maupun
Metastasis Jauh di RSUP Hasan Sadikin Bandung [skripsi]. Malang: Universitas
Muhammadiyah Malang; 2008.
24. Ramli, M. Update Breast Cancer Management, Diagnostic, and Treatment. MKA J. 2015;
38(1):28-53.
25. Mariotto A.B., Etzioni R.,Hulbert M., Panberthy L., Mayer, M. Estimation of the Number
of Woman Living with Metastatic Breast Cancer in the United States. Cancer Epidemiol
Biomarkers Prev. 2017;1:1-6.
26. Chen, M., Sun, H. Zhao Y., Fu W.Y., Yang L.P., Gao S.P. et al. Comparison of Pattern
amd Prognostic Among Distant Metastatic Breast Cancer Patients by Age Groups: a SEER
Population-based Analysis. Scie Rep. 2017;7:1-8.
27. Wijaya, I.G., Manuaba, I.B. Hubungan Subtipe Imunohistokimia dengan Usia pada
Pasien Kanker Payudara di Rsup Sanglah Kota Denpasar. E Jour Med. [Link]-5.
28. Kumar B.N., Patni P., Agarwal A., Khan M.A., Parashar N. Prevalence of molecular
subtypes of invasive breast cancer: A retrospective study. Med J Armed Forces Ind. 2015; 71:
254-8.
29. Nurwenda S., Birgitta M., Dewayani, Afiati, Bethy S. Hernowo. Ekspresi Negatif
Melanoma Cell Adhesion Molecule (MCAM) Berkorelasi dengan Metastasis Kelenjar Getah
Bening Aksila pada Triple Negative Breast Cancer. J Farm Klin Indo. 2016;5(3): 204–14.
30. Wu1 Q., Li1 J., Zhu1 S., Wu J., Chen C., Liu Q., et al. Breast cancer subtypes predict the
preferential site of distant metastases: a SEER based study. Oncotarget J. 2017;8(17): 27990-
6.
31. American Cancer Society. Breast Cancer Facts & Figures 2015-2016. Atlanta: American
Cancer Society; 2015.
32. Hoe A.H., Royle T.. Breast liver metastases- incidence, diagnosis and outcome. J Royal
Socie Med. 1991;84:714-6.
Tanpa nomor
Verma V., Sarin S.K, Sharma P., Kumar A. Correlation of aspartate aminotransferase/platelet
ratio index with hepatic venous pressure gradient in cirrhosis. United European
Gastroenterology J. 2014;2(3):226–31.
Saika K., Sobue T. Epidemiology of Breast Cancer in Japan and the US. JMAJ. 2009; 52(1):
39–44.
Ostad S.N., Parsa M. Breast Cancer from Molecular Point of View: Pathogenesis and
Biomarkers, Breast Cancer - Focusing Tumor Microenvironment, Stem cells and Metastasis,
Prof. Mehmet Gunduz (Ed.). URL Available from: [Link]
cancer-focusing-tumor-microenvironment-stem-cells-and-metastasis/breast-cancer-from-
molecular-point-of-view-pathogenesis-and-biomarkers. Accessed September 27, 2018.
Angahar L.T. An overview of breast cancer epidemiology, risk factors, pathophysiology, and
cancer risks reduction. MOJ Biol Med. 2017;1(4):92‒96.
Coughlin S., Cypel Y. Epidemiology of Breast Cancer in Women in Breast Cancer
Metastasis and Drug Resistance. New York: Springer; 2012. p. 19-34.
Willet A., Wilkinson J.B., Shah C., Mehta M.P. Management of solitary and multiple brain
metastases from breast cancer. Indian J Med Paediatr Oncol. 2015;36(2): 87–93.
